Alternative Therapies in Transplantology as a Promising Perspective in Medicine.

Despite continuous and rapid progress in the transplantation of cells, tissues, and organs, many patients die before receiving them. This is because of an insufficient number of donors, which leads to a significant disproportion between the need for donors and their availability. This review aims to present the possibilities offered by alternative therapies. We use the term "functional transplantology" to describe such alternative methods of transplantation that could help change the current state of transplantation medicine. Its purpose is not to replace a defective or removed organ with another but to replace its functions using complementary biological, mechanical, or biomechanical structures or devices. Implementation of many innovative solutions shown in the work for clinical applications is already a fact. In the case of others, it should be considered a future vision. We hope that the role of a defective or damaged tissue or a group of tissues will be taken over by different structures that are functionally complementary with the organ being substituted. Undoubtedly, developing the described methods based on functional transplantology will change the face of transplantation medicine. Thus, we show current trends and new directions of thinking and actions in transplantation medicine that combine technology and transplantology. The review considers the latest technologies, including 3D bioprinting, nanotechnology, cell encapsulation, and organoids. We discuss not only the advantages of new approaches but also the limitations and challenges that must be overcome to achieve significant progress in transplantation. That is the only option to provide a safe and efficient way of improving the quality of life of many patients.

miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy.

Breast cancer is one of the most commonly diagnosed cancer types worldwide. Regarding molecular characteristics and classification, it is a heterogeneous disease, which makes it more challenging to diagnose. As is commonly known, early detection plays a pivotal role in decreasing mortality and providing a better prognosis for all patients. Different treatment strategies can be adjusted based on tumor progression and molecular characteristics, including personalized therapies. However, dealing with resistance to drugs and recurrence is a challenge. The therapeutic options are limited and can still lead to poor clinical outcomes. This review aims to shed light on the current perspective on the role of miRNAs in breast cancer diagnostics, characteristics, and prognosis. We discuss the potential role of selected non-coding RNAs most commonly associated with breast cancer. These include miR-21, miR-106a, miR-155, miR-141, let-7c, miR-335, miR-126, miR-199a, miR-101, and miR-9, which are perceived as potential biomarkers in breast cancer prognosis, diagnostics, and treatment response monitoring. As miRNAs differ in expression levels in different types of cancer, they may provide novel cancer therapy strategies. However, some limitations regarding dynamic alterations, tissue-specific profiles, and detection methods must also be raised.

New anionic rhodium complexes as catalysts for the reduction of acetophenone and its derivatives.

New anionic rhodium(iii) complexes, obtained by a simple reaction of RhCl3 with organic chlorides (derivatives of imidazole and pyridine), have been employed as catalysts for hydrosilylation (reduction) of acetophenone derivatives. The reactions, in which 1,1,1,3,5,5,5-heptamethyltrisiloxane was a reducing agent, proceeded in a biphasic system because the above complexes are insoluble in the reaction medium. Thereby easy isolation of the complexes from post-reaction mixtures was possible after reaction completion. This is the first example of the application of rhodium complexes of this type as catalysts for ketone reduction. The complexes have shown high activity and enabled obtaining the hydrosilylation product in a very short time and in the range of low concentrations (0.1 mol%). By using FT-IR in situ analysis that enables measuring product concentrations in real time, a comparison has been made of the catalytic activity for hydrosilylation of acetophenone and methoxyacetophenone isomers shown by four rhodium complexes ([C+][RhCl4 -]) differing in cations and the most effective catalyst for this process has been distinguished.

Silica Surface Modification and Its Application in Permanent Link with Nucleic Acids.

In this paper, the Pt-catalyzed hydrosilylation of hydroxyl ethers is described. Various bifunctional alkoxysilanes were obtained and applied in O-silylation of free hydroxyl groups on the silica surface. These modified solid materials have been used as excellent supports for linking synthetic nucleic acids. Nucleic acids permanently attached to the solid surface were tested in hybridization with complementary fluorescence-labeled sequences. Detection of nucleic acids anchored to the solid support was performed by fluorescence microscopy after hybridization.

The effect of the morpholinium ionic liquid anion on the catalytic activity of Rh (or Pt) complex-ionic liquid systems in hydrosilylation processes.

Studies were performed on the catalytic activity for olefin hydrosilylation shown by three rhodium complexes, [{Rh(µ-OSiMe3)(cod)}2] (I), [{Rh(µ-Cl)(cod)}2] (II) and [RhCl(PPh3)3] (III), and three platinum complexes, [Pt(PPh3)4] (IV), [Pt(PPh3)2Cl2] (V) and PtCl4 (VI), immobilized in a series of different anion-containing morpholinium ionic liquids. The effect of the kind of anion (its nucleophilic character) on the activity, stability and possibility of a catalytic system with multiple uses in the hydrosilylation process has been established. In the case of the best systems it was possible to reuse the same catalyst sample 10 times almost without any decrease in the activity and a TON value over 99 000 was obtained.

A new catalytic route to boryl- and borylsilyl-substituted buta-1,3-dienes.

Vinyl-substituted boronates in the presence of complexes containing Ru-H bonds (preferably [Ru(CO)ClH(PCy(3))(2)], Cy: cyclohexyl) react regioselectively with terminal ethynes (involving silylethynes), albeit with the exception of phenylacetylene, to produce boryl- and borylsilyl-substituted buta-1,3-dienes with a preference for E,E-diene. The reaction opens a new catalytic route for the preparation of dienylboronates, and particularly dienylsilylboronates, that are functionalised building blocks in the synthesis of organic and natural products. The mechanism of this new reaction was proved to involve an insertion of alkyne into Ru-H bonds followed by an insertion of coordinated vinyl boronate into the Ru-C= bond and beta-hydrogen transfer to the metal to eliminate boryldiene or borylsilyldiene.